In addition, the results obtained by: blocking ligand secretion; treatment with specific anti-Wnt9A antibody; and treatment with recombinant Wnt9A protein all point to a role for Wnt9A in the suppression of CRC cells we report herein. This evidence concerns the gene WNT9A and colorectal carcinoma.